|
|
 |
|
Viewing report
|
|
|
|
Malaysia Pharmaceuticals and Healthcare Report Q2 2011
Business Monitor International, March 2011, Pages: 112
Business Monitor International's Malaysia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Malaysia's pharmaceuticals and healthcare industry.
Product Description
The Malaysia Pharmaceuticals & Healthcare Report features Business Monitor International (BMI)’s 5 and 10-year forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.
BMI’s Malaysia Pharmaceuticals & Healthcare Report provides industry professionals, market investors and corporate and financial services analysts with independent forecasts and competitive intelligence on the Malaysian pharmaceutical and healthcare industry.
Key Benefits
- Benchmark BMI’s independent 5 and 10-year pharmaceutical and healthcare industry forecasts on Malaysia to test other views – a key input for successful budgeting and strategic business planning in the Malaysian pharmaceutical and healthcare market.
- Target business opportunities and risks in the Malaysian pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in Malaysia.
- Assess the activities, strategy and market position of your competitors, partners and clients via our Company Profiles (inc. SWOTs, KPIs, latest activity) and Competitive Landscape Tables.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
